The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO GI 2021 | ASCO GI 2021: highlighting progress in rare cancers
Gayathri Anandappa, MBBS, MRCP, MPhil, The Royal Marsden NHS Foundation Trust, London, UK, discusses highlights from the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium, touching on progress in patients with rare cancers such as cholangiocarcinoma and hepatocellular carcinoma, as well as the importance of developing novel approaches for patients with pancreatic cancers. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).
